retatrutide mechanism retatrutide clinical trials 2024 2025 💉 may be redefining obesity treatment. New data from TRIUMPH-1 Trial showed: 🔥 ~28% average weight loss over 80 weeks 🔥 >30% weight loss in nearly half of participant #ObesityMedicine #Retatrutide #GLP1 #CardioMetabolic The Science Behind Retatrutide: A

Weight loss remains steady, averaging 1 to 1.5 pounds per week

To induce OA, the rabbits were first anesthetized using a combination of xylazine and ketamine

However, among patients with T2DM, there was no association between GLP-1 RAs and new-onset cancers, such as pancreatic cancer, thyroid cancer, and MTC

occurs mostly in adults and may originate de novo or from a pigmented nevus or lentigo maligna

Therefore, regulation of ferroptosis in cardiomyocyte and attenuation of myocardial inflammation in DCM by Nrf2 may provide new therapeutic options for DCM

This "incretin effect" is one of the primary reasons GLP-1 medications were originally developed for type 2 diabetes before their weight loss applications became apparent